MGNet: New Assay Evaluates Acetylcholine Receptor Autoantibody–Mediated Complement Activity in Myasthenia Gravis

Aug 15, 2022 · 1m 42s
MGNet: New Assay Evaluates Acetylcholine Receptor Autoantibody–Mediated Complement Activity in Myasthenia Gravis
Description

New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal Neuroimmunology & Neuroinflammation on April 26, 2022, titled "Heterogeneity...

show more
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal Neuroimmunology & Neuroinflammation on April 26, 2022, titled "Heterogeneity of Acetylcholine Receptor Autoantibody–Mediated Complement Activity in Patients With Myasthenia Gravis."

Read the paper here: https://nn.neurology.org/content/9/4/e1169

Learn more about MGNet: https://www.rarediseasesnetwork.org/mgnet
show less
Information
Author RDCRN
Organization RDCRN
Website -
Tags

Looks like you don't have any active episode

Browse Spreaker Catalogue to discover great new content

Current

Podcast Cover

Looks like you don't have any episodes in your queue

Browse Spreaker Catalogue to discover great new content

Next Up

Episode Cover Episode Cover

It's so quiet here...

Time to discover new episodes!

Discover
Your Library
Search